 | • レポートコード：MRC23Q36241 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の一般用医薬品市場について調査・分析し、世界の一般用医薬品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他）、用途別セグメント分析（薬局、病院薬局、ネット通販、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euraditeなどが含まれています。 世界の一般用医薬品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、一般用医薬品市場規模を推定する際に考慮しました。本レポートは、一般用医薬品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、一般用医薬品に関するビジネス上の意思決定に役立てることを目的としています。 ・一般用医薬品市場の概要 - 一般用医薬品のタイプ別セグメント - 世界の一般用医薬品市場規模：タイプ別分析（消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他） - 一般用医薬品の用途別セグメント - 世界の一般用医薬品市場規模：用途別分析（薬局、病院薬局、ネット通販、その他） - 世界の一般用医薬品市場規模予測（2018年-2029年） ・一般用医薬品市場の成長トレンド - 一般用医薬品の地域別市場規模（2018年-2029年） - 一般用医薬品市場ダイナミクス - 一般用医薬品の業界動向 - 一般用医薬品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：消化器、皮膚科、耳鼻咽喉科、栄養/ビタミン、その他 - 世界の一般用医薬品のタイプ別市場規模（2018年-2023年） - 世界の一般用医薬品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：薬局、病院薬局、ネット通販、その他 - 世界の一般用医薬品の用途別市場規模（2018年-2023年） - 世界の一般用医薬品の用途別市場規模（2024年-2029年） ・一般用医薬品の地域別市場規模 - 北米の一般用医薬品市場規模（2018年-2029年） - アメリカの一般用医薬品市場規模（2018年-2029年） - ヨーロッパの一般用医薬品市場規模（2018年-2029年） - アジア太平洋の一般用医薬品市場規模（2018年-2029年） - 中国の一般用医薬品市場規模（2018年-2029年） - 日本の一般用医薬品市場規模（2018年-2029年） - 韓国の一般用医薬品市場規模（2018年-2029年） - インドの一般用医薬品市場規模（2018年-2029年） - オーストラリアの一般用医薬品市場規模（2018年-2029年） - 中南米の一般用医薬品市場規模（2018年-2029年） - 中東・アフリカの一般用医薬品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Procter & Gamble、Johnson & Johnson、GlaxoSmithKline Plc、Abbott Laboratories、Amway Corporation、Bayer、Aktienge、Sanofi、Pfizer、Reckitt Benckiser Group、Church & Dwight、Bayer HealthCare、AstraZeneca、BioGaia、Bristol Myers Squibb、Chr. Hansen、Cipla、CoLucid、Daiichi Sankyo、Friggs、DSM、Eisai、Eli Lilly、Herbalife、Euradite ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global OTC Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for OTC Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for OTC Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for OTC Medicine in Pharmacy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of OTC Medicine include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer, Aktienge, Sanofi and Pfizer, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OTC Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Medicine.
The OTC Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global OTC Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Procter & Gamble
Johnson & Johnson
GlaxoSmithKline Plc
Abbott Laboratories
Amway Corporation
Bayer
Aktienge
Sanofi
Pfizer
Reckitt Benckiser Group
Church & Dwight
Bayer HealthCare
AstraZeneca
BioGaia
Bristol Myers Squibb
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Segment by Type
Gastrointestinal Tract
Dermatology
Otolaryngology
Nutrition/Vitamins
Others
Segment by Application
Pharmacy
Hospital Pharmacy
Online Retailer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gastrointestinal Tract
1.2.3 Dermatology
1.2.4 Otolaryngology
1.2.5 Nutrition/Vitamins
1.2.6 Others
1.3 Market by Application
1.3.1 Global OTC Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Online Retailer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Medicine Market Perspective (2018-2029)
2.2 OTC Medicine Growth Trends by Region
2.2.1 Global OTC Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Medicine Historic Market Size by Region (2018-2023)
2.2.3 OTC Medicine Forecasted Market Size by Region (2024-2029)
2.3 OTC Medicine Market Dynamics
2.3.1 OTC Medicine Industry Trends
2.3.2 OTC Medicine Market Drivers
2.3.3 OTC Medicine Market Challenges
2.3.4 OTC Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Medicine Players by Revenue
3.1.1 Global Top OTC Medicine Players by Revenue (2018-2023)
3.1.2 Global OTC Medicine Revenue Market Share by Players (2018-2023)
3.2 Global OTC Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Medicine Revenue
3.4 Global OTC Medicine Market Concentration Ratio
3.4.1 Global OTC Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Medicine Revenue in 2022
3.5 OTC Medicine Key Players Head office and Area Served
3.6 Key Players OTC Medicine Product Solution and Service
3.7 Date of Enter into OTC Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Medicine Breakdown Data by Type
4.1 Global OTC Medicine Historic Market Size by Type (2018-2023)
4.2 Global OTC Medicine Forecasted Market Size by Type (2024-2029)
5 OTC Medicine Breakdown Data by Application
5.1 Global OTC Medicine Historic Market Size by Application (2018-2023)
5.2 Global OTC Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Medicine Market Size (2018-2029)
6.2 North America OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Medicine Market Size by Country (2018-2023)
6.4 North America OTC Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Medicine Market Size (2018-2029)
7.2 Europe OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Medicine Market Size by Country (2018-2023)
7.4 Europe OTC Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Medicine Market Size (2018-2029)
8.2 Asia-Pacific OTC Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific OTC Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Medicine Market Size (2018-2029)
9.2 Latin America OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Medicine Market Size by Country (2018-2023)
9.4 Latin America OTC Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Medicine Market Size (2018-2029)
10.2 Middle East & Africa OTC Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa OTC Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Procter & Gamble
11.1.1 Procter & Gamble Company Detail
11.1.2 Procter & Gamble Business Overview
11.1.3 Procter & Gamble OTC Medicine Introduction
11.1.4 Procter & Gamble Revenue in OTC Medicine Business (2018-2023)
11.1.5 Procter & Gamble Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson OTC Medicine Introduction
11.2.4 Johnson & Johnson Revenue in OTC Medicine Business (2018-2023)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Detail
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc OTC Medicine Introduction
11.3.4 GlaxoSmithKline Plc Revenue in OTC Medicine Business (2018-2023)
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories OTC Medicine Introduction
11.4.4 Abbott Laboratories Revenue in OTC Medicine Business (2018-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Amway Corporation
11.5.1 Amway Corporation Company Detail
11.5.2 Amway Corporation Business Overview
11.5.3 Amway Corporation OTC Medicine Introduction
11.5.4 Amway Corporation Revenue in OTC Medicine Business (2018-2023)
11.5.5 Amway Corporation Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer OTC Medicine Introduction
11.6.4 Bayer Revenue in OTC Medicine Business (2018-2023)
11.6.5 Bayer Recent Development
11.7 Aktienge
11.7.1 Aktienge Company Detail
11.7.2 Aktienge Business Overview
11.7.3 Aktienge OTC Medicine Introduction
11.7.4 Aktienge Revenue in OTC Medicine Business (2018-2023)
11.7.5 Aktienge Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi OTC Medicine Introduction
11.8.4 Sanofi Revenue in OTC Medicine Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer OTC Medicine Introduction
11.9.4 Pfizer Revenue in OTC Medicine Business (2018-2023)
11.9.5 Pfizer Recent Development
11.10 Reckitt Benckiser Group
11.10.1 Reckitt Benckiser Group Company Detail
11.10.2 Reckitt Benckiser Group Business Overview
11.10.3 Reckitt Benckiser Group OTC Medicine Introduction
11.10.4 Reckitt Benckiser Group Revenue in OTC Medicine Business (2018-2023)
11.10.5 Reckitt Benckiser Group Recent Development
11.11 Church & Dwight
11.11.1 Church & Dwight Company Detail
11.11.2 Church & Dwight Business Overview
11.11.3 Church & Dwight OTC Medicine Introduction
11.11.4 Church & Dwight Revenue in OTC Medicine Business (2018-2023)
11.11.5 Church & Dwight Recent Development
11.12 Bayer HealthCare
11.12.1 Bayer HealthCare Company Detail
11.12.2 Bayer HealthCare Business Overview
11.12.3 Bayer HealthCare OTC Medicine Introduction
11.12.4 Bayer HealthCare Revenue in OTC Medicine Business (2018-2023)
11.12.5 Bayer HealthCare Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Detail
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca OTC Medicine Introduction
11.13.4 AstraZeneca Revenue in OTC Medicine Business (2018-2023)
11.13.5 AstraZeneca Recent Development
11.14 BioGaia
11.14.1 BioGaia Company Detail
11.14.2 BioGaia Business Overview
11.14.3 BioGaia OTC Medicine Introduction
11.14.4 BioGaia Revenue in OTC Medicine Business (2018-2023)
11.14.5 BioGaia Recent Development
11.15 Bristol Myers Squibb
11.15.1 Bristol Myers Squibb Company Detail
11.15.2 Bristol Myers Squibb Business Overview
11.15.3 Bristol Myers Squibb OTC Medicine Introduction
11.15.4 Bristol Myers Squibb Revenue in OTC Medicine Business (2018-2023)
11.15.5 Bristol Myers Squibb Recent Development
11.16 Chr. Hansen
11.16.1 Chr. Hansen Company Detail
11.16.2 Chr. Hansen Business Overview
11.16.3 Chr. Hansen OTC Medicine Introduction
11.16.4 Chr. Hansen Revenue in OTC Medicine Business (2018-2023)
11.16.5 Chr. Hansen Recent Development
11.17 Cipla
11.17.1 Cipla Company Detail
11.17.2 Cipla Business Overview
11.17.3 Cipla OTC Medicine Introduction
11.17.4 Cipla Revenue in OTC Medicine Business (2018-2023)
11.17.5 Cipla Recent Development
11.18 CoLucid
11.18.1 CoLucid Company Detail
11.18.2 CoLucid Business Overview
11.18.3 CoLucid OTC Medicine Introduction
11.18.4 CoLucid Revenue in OTC Medicine Business (2018-2023)
11.18.5 CoLucid Recent Development
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Detail
11.19.2 Daiichi Sankyo Business Overview
11.19.3 Daiichi Sankyo OTC Medicine Introduction
11.19.4 Daiichi Sankyo Revenue in OTC Medicine Business (2018-2023)
11.19.5 Daiichi Sankyo Recent Development
11.20 Friggs
11.20.1 Friggs Company Detail
11.20.2 Friggs Business Overview
11.20.3 Friggs OTC Medicine Introduction
11.20.4 Friggs Revenue in OTC Medicine Business (2018-2023)
11.20.5 Friggs Recent Development
11.21 DSM
11.21.1 DSM Company Detail
11.21.2 DSM Business Overview
11.21.3 DSM OTC Medicine Introduction
11.21.4 DSM Revenue in OTC Medicine Business (2018-2023)
11.21.5 DSM Recent Development
11.22 Eisai
11.22.1 Eisai Company Detail
11.22.2 Eisai Business Overview
11.22.3 Eisai OTC Medicine Introduction
11.22.4 Eisai Revenue in OTC Medicine Business (2018-2023)
11.22.5 Eisai Recent Development
11.23 Eli Lilly
11.23.1 Eli Lilly Company Detail
11.23.2 Eli Lilly Business Overview
11.23.3 Eli Lilly OTC Medicine Introduction
11.23.4 Eli Lilly Revenue in OTC Medicine Business (2018-2023)
11.23.5 Eli Lilly Recent Development
11.24 Herbalife
11.24.1 Herbalife Company Detail
11.24.2 Herbalife Business Overview
11.24.3 Herbalife OTC Medicine Introduction
11.24.4 Herbalife Revenue in OTC Medicine Business (2018-2023)
11.24.5 Herbalife Recent Development
11.25 Euradite
11.25.1 Euradite Company Detail
11.25.2 Euradite Business Overview
11.25.3 Euradite OTC Medicine Introduction
11.25.4 Euradite Revenue in OTC Medicine Business (2018-2023)
11.25.5 Euradite Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details